Morris CM - Search Results

1

Presenilin polymorphisms in Alzheimer's disease.

Singleton AB, Gibson AM, Atkinson AL, Daly A, Morris CM. Singleton AB, et al. Among authors: morris cm. Lancet. 1997 Sep 27;350(9082):958-9. doi: 10.1016/s0140-6736(05)63299-0. Lancet. 1997. PMID: 9314892 No abstract available.

2

Protective effect of apoE epsilon 2 in Alzheimer's disease.

Benjamin R, Leake A, McArthur FK, Ince PG, Candy JM, Edwardson JA, Morris CM, Bjertness E. Benjamin R, et al. Among authors: morris cm. Lancet. 1994 Aug 13;344(8920):473. doi: 10.1016/s0140-6736(94)91804-x. Lancet. 1994. PMID: 7914580 No abstract available.

3

Apolipoprotein E genotyping in Alzheimer's disease.

McKeith IG, Morris CM. McKeith IG, et al. Among authors: morris cm. Lancet. 1996 Jun 22;347(9017):1775. Lancet. 1996. PMID: 8656943 No abstract available.

4

No association between an intronic polymorphism in the presenilin-1 gene and Alzheimer's disease.

Singleton AB, Lamb H, Leake A, McKeith IG, Perry RH, Morris CM. Singleton AB, et al. Among authors: morris cm. Neurosci Lett. 1997 Sep 26;234(1):19-22. doi: 10.1016/s0304-3940(97)00653-8. Neurosci Lett. 1997. PMID: 9347936

5

No association between a polymorphism in the presenilin 1 gene and dementia with Lewy bodies.

Singleton AB, Lamb H, Leake A, McKeith IG, Ince PG, Perry RH, Morris CM. Singleton AB, et al. Among authors: morris cm. Neuroreport. 1997 Nov 10;8(16):3637-9. doi: 10.1097/00001756-199711100-00042. Neuroreport. 1997. PMID: 9427340

6

D2 dopamine receptor gene (DRD2) Taq1 A polymorphism: reduced dopamine D2 receptor binding in the human striatum associated with the A1 allele.

Thompson J, Thomas N, Singleton A, Piggott M, Lloyd S, Perry EK, Morris CM, Perry RH, Ferrier IN, Court JA. Thompson J, et al. Among authors: morris cm. Pharmacogenetics. 1997 Dec;7(6):479-84. doi: 10.1097/00008571-199712000-00006. Pharmacogenetics. 1997. PMID: 9429233

7

Apolipoprotein E and alpha-1 antichymotrypsin polymorphism genotyping in Alzheimer's disease and in dementia with Lewy bodies. Distinctions between diseases.

Lamb H, Christie J, Singleton AB, Leake A, Perry RH, Ince PG, McKeith IG, Melton LM, Edwardson JA, Morris CM. Lamb H, et al. Among authors: morris cm. Neurology. 1998 Feb;50(2):388-91. doi: 10.1212/wnl.50.2.388. Neurology. 1998. PMID: 9484359

8

No association between the K variant of the butyrylcholinesterase gene and pathologically confirmed Alzheimer's disease.

Singleton AB, Smith G, Gibson AM, Woodward R, Perry RH, Ince PG, Edwardson JA, Morris CM. Singleton AB, et al. Among authors: morris cm. Hum Mol Genet. 1998 May;7(5):937-9. doi: 10.1093/hmg/7.5.937. Hum Mol Genet. 1998. PMID: 9536100

9

Butyrylcholinesterase K: an association with dementia with Lewy bodies.

Singleton AB, Gibson AM, Edwardson JA, McKeith IG, Morris CM. Singleton AB, et al. Among authors: morris cm. Lancet. 1998 Jun 13;351(9118):1818. doi: 10.1016/s0140-6736(05)78788-2. Lancet. 1998. PMID: 9635987 No abstract available.

10

LRP gene and late-onset Alzheimer's disease.

Woodward R, Singleton AB, Gibson AM, Edwardson JA, Morris CM. Woodward R, et al. Among authors: morris cm. Lancet. 1998 Jul 18;352(9123):239-40. doi: 10.1016/s0140-6736(05)77848-x. Lancet. 1998. PMID: 9683245 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

317 results

Search Page

Filters